Technology

Efficient and accurate dosing is achieved through high respirable fractions and breath-actuated delivery.

Pneuma’s platform delivers API formulations in aqueous based solutions.

Insoluble API formulations (e.g., corticosteroids such as budesonide) can also be delivered efficiently using nano and micro suspensions.
Cannabinoids can be delivered via Pneuma’s platform using proprietary formulations.
Pneuma’s unique device platform allows for large, fragile biologic molecules to be delivered to the lungs without shearing, which maximizes the efficiency of costly biologic drugs.

Aerosols are produced with very high respirable fractions, allowing for the delivery of a lower concentration of API for effective dosage, improving the safety profile. This is especially important when delivering steroids.
Pneuma’s platform has fingerprint authorization capability for controlled substances and to prevent underage use.
RFID chip on cartridge ensures it is genuine and is not refilled with potentially dangerous substances.
No heating therefore no thermally generated chemical byproducts.

Pneuma’s fully digital platform provides a unique and comfortable user experience with voice coaching to ensure patients follow instructions for inhalation.
Aerosol delivery can be tailored to individual needs.